|
gptkbp:instanceOf
|
research organization
|
|
gptkbp:affiliatedWith
|
gptkb:University_of_Oxford
|
|
gptkbp:area
|
over 100 researchers
|
|
gptkbp:clinicalTrials
|
HIV vaccine trials
Ebola vaccine trials
influenza vaccine trials
Nipah virus vaccine trials
RSV vaccine trials
SARS-CoV-2 vaccine trials
Zika vaccine trials
dengue vaccine trials
malaria vaccine trials
meningitis vaccine trials
tuberculosis vaccine trials
COVID-19_vaccine_trials
|
|
gptkbp:collaboratesWith
|
gptkb:AstraZeneca
gptkb:NIHR
|
|
gptkbp:director
|
Andrew_Pollard
|
|
gptkbp:focus
|
vaccine development
|
|
gptkbp:founded
|
1996
|
|
gptkbp:funding
|
gptkb:UK_government
|
|
gptkbp:goal
|
improve public health
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Oxford Vaccine Group
|
|
gptkbp:impact
|
global vaccination efforts
|
|
gptkbp:location
|
gptkb:Oxford,_England
|
|
gptkbp:notableWork
|
gptkb:Oxford-AstraZeneca_COVID-19_vaccine
|
|
gptkbp:partnerships
|
gptkb:Global_Fund
gptkb:Merck
gptkb:GSK
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:CEPI
gptkb:Janssen_Pharmaceuticals
gptkb:Novavax
gptkb:Pfizer
gptkb:Moderna
Sanofi
WHO
PATH
|
|
gptkbp:publications
|
vaccine research papers
|
|
gptkbp:research
|
philanthropic donations
|
|
gptkbp:researchAreas
|
infectious diseases
|
|
gptkbp:website
|
www.ovg.ox.ac.uk
|